Scarica l'app Stockscreener
1.13
4.63%
0.05
Precedente Chiudi:
$1.08
Aprire:
$1.1
Volume 24 ore:
46,114
Relative Volume:
0.64
Capitalizzazione di mercato:
$9.41M
Reddito:
$6.74M
Utile/perdita netta:
$-14.74M
Rapporto P/E:
-0.5024
EPS:
-2.2491
Flusso di cassa netto:
$-18.31M
1 W Prestazione:
-6.61%
1M Prestazione:
-13.08%
6M Prestazione:
-4.64%
1 anno Prestazione:
-29.38%
Intervallo 1D:
$1.085
$1.145
Intervallo di 1 settimana:
$1.08
$1.2476
Portata 52W:
$0.95
$2.42
Evogene Ltd Stock (EVGN) Company Profile
Confronta EVGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.13 | 9.41M | 6.74M | -14.74M | -18.31M | -2.2491 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-29 | Iniziato | Aegis Capital | Buy |
| 2020-12-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Iniziato | Oppenheimer | Outperform |
Evogene Ltd Borsa (EVGN) Ultime notizie
Evogene Ltd. Earnings Call: Strategic Shifts and Optimism - The Globe and Mail
Is Evogene Ltd. stock cheap compared to fundamentals - newser.com
Evogene Ltd. (NASDAQ:EVGN) Q3 2025 Earnings Call Transcript - Insider Monkey
What drives Evogene Ltd stock priceRelative Strength Index (RSI) & Big Gains Small Budget - earlytimes.in
Can Evogene Ltd. stock hit record highs again2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
Is Evogene Ltd. stock oversold or undervalued2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
Evogene Ltd. Reports Strategic Shift and Financial Results - TipRanks
Evogene: Q3 Earnings Snapshot - Stamford Advocate
Evogene earnings beat by $0.12, revenue fell short of estimates - Investing.com Australia
Evogene Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Evogene reports Q3 2025 earnings beat amid restructuring - Investing.com India
Evogene shares climb 5% as cost reductions help deliver earnings beat - MSN
Evogene shares rise 5% as cost-cutting measures drive earnings beat - Investing.com Nigeria
Evogene Reports Third Quarter 2025 Financial Results - The AI Journal
Evogene Reports Q3 2025 Financial Results Amid Strategic Shift - TipRanks
Israeli biotech firm Evogene's Q3 revenue misses estimates due to reduced seed sales - TradingView
Will Evogene Ltd. stock outperform international peers2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Evogene Ltd. stock maintain growth storyMarket Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
Is Evogene Ltd. stock a buy for dividend growthJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - newser.com
How strong is Evogene Ltd. stock revenue growthCEO Change & Free Community Consensus Stock Picks - newser.com
Evogene Ltd. stock prediction for this weekGDP Growth & Weekly Top Gainers Trade List - newser.com
What technical models suggest about Evogene Ltd.’s comeback2025 Performance Recap & Reliable Intraday Trade Plans - newser.com
What's Next: Evogene's Earnings Preview - Benzinga
Visual trend scoring systems applied to Evogene Ltd.Weekly Investment Recap & Stock Timing and Entry Methods - newser.com
Can Evogene Ltd. stock withstand economic slowdownMarket Growth Summary & Stock Portfolio Risk Management - newser.com
Evogene Ltd Azioni (EVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):